Inivata
Mike Nahorski has extensive experience in the medical and scientific field, with roles such as Director of Clinical & Scientific Alliances at Inivata, Medical Science Liaison at Eli Lilly and Company, and various roles at the University of Cambridge and University of Birmingham. Their work involved a range of responsibilities, from supporting the launch of medical products to conducting research and teaching undergraduate students.
Mike Nahorski completed their Doctor of Philosophy (Ph.D.) in The Molecular Genetics of Inherited Renal Cancer at the University of Birmingham from 2008 to 2012.
This person is not in any offices
Inivata
1 followers
Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and backed by multiple high calibre publications.